SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,192 | -47.6% | 43,358 | +5.5% | 0.00% | – |
| Q2 2023 | $196,851 | -0.9% | 41,096 | +17.3% | 0.00% | – |
| Q1 2023 | $198,603 | +3.7% | 35,027 | +2.4% | 0.00% | – |
| Q4 2022 | $191,486 | -94.8% | 34,194 | -94.0% | 0.00% | -100.0% |
| Q3 2022 | $3,657,000 | +3350.0% | 569,597 | +1752.5% | 0.00% | – |
| Q2 2022 | $106,000 | -52.9% | 30,748 | -3.1% | 0.00% | – |
| Q1 2022 | $225,000 | -14.8% | 31,726 | -0.0% | 0.00% | – |
| Q4 2021 | $264,000 | -6.0% | 31,729 | -21.2% | 0.00% | – |
| Q3 2021 | $281,000 | -65.0% | 40,249 | +19.6% | 0.00% | – |
| Q2 2021 | $802,000 | +167.3% | 33,645 | +131.1% | 0.00% | – |
| Q1 2021 | $300,000 | +18.1% | 14,558 | +40.1% | 0.00% | – |
| Q4 2020 | $254,000 | -87.9% | 10,389 | -86.0% | 0.00% | -100.0% |
| Q3 2020 | $2,093,000 | – | 73,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |